scispace - formally typeset
M

Maria G. Belvisi

Researcher at National Institutes of Health

Publications -  275
Citations -  17371

Maria G. Belvisi is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Sensory nerve & Cholinergic. The author has an hindex of 73, co-authored 269 publications receiving 16021 citations. Previous affiliations of Maria G. Belvisi include Aventis Pharma & AstraZeneca.

Papers
More filters
Journal ArticleDOI

IκB Kinase-2-Independent and -Dependent Inflammation in Airway Disease Models: Relevance of IKK-2 Inhibition to the Clinic

TL;DR: This is the first study to examine the effect of an IKK-2 inhibitor in well validated models that mimic aspects of the inflammatory lesion evident in diseases such as COPD and may lead to greater understanding of disease pathology and the discovery of novel anti-inflammatory targets.
Journal ArticleDOI

Inhibition of cholinergic neurotransmission in human airways by opioids.

TL;DR: It is concluded that mu-opioid agonists inhibit cholinergic neurotransmission in human airways in vitro, and this could have therapeutic potential in the treatment of airway disease.
Journal ArticleDOI

Pre-clinical studies in cough research: Role of Transient Receptor Potential (TRP) channels

TL;DR: In vitro and in vivo models that are currently used to further the understanding of the sensory innervation of the respiratory tract, and how these nerves are involved in controlling the cough response are focused on.
Journal ArticleDOI

Steroid-resistant Inflammation in a Rat Model of Chronic Obstructive Pulmonary Disease Is Associated with a Lack of Nuclear Factor-κB Pathway Activation

TL;DR: This model, in addition to its suitability for testing therapies that may modify existing emphysema, could be useful in the search for new therapies to reduce the steroid-resistant airway inflammation evident in COPD.